These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9695716)

  • 21. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
    Song ZH; Takemori AE
    Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
    Egan TD; Lemmens HJ; Fiset P; Hermann DJ; Muir KT; Stanski DR; Shafer SL
    Anesthesiology; 1993 Nov; 79(5):881-92. PubMed ID: 7902032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linearity of pharmacokinetics and model estimation of sufentanil.
    Gepts E; Shafer SL; Camu F; Stanski DR; Woestenborghs R; Van Peer A; Heykants JJ
    Anesthesiology; 1995 Dec; 83(6):1194-204. PubMed ID: 8533912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
    Butelman ER; Vivian JA; Yu J; Kreek MJ; Woods JH
    Psychopharmacology (Berl); 1999 Apr; 143(2):190-6. PubMed ID: 10326782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An HPLC/RIA method for dynorphin A1-13 and its main metabolites in human blood.
    Müller S; Ho B; Gambus P; Millard W; Hochhaus G
    J Pharm Biomed Anal; 1997 Sep; 16(1):101-9. PubMed ID: 9447557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesic effects of dynorphin-A and morphine in mice.
    Nakazawa T; Ikeda M; Kaneko T; Yamatsu K
    Peptides; 1985; 6(1):75-8. PubMed ID: 2859574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
    Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
    Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific binding and clearance of [3H]dynorphin (1-13) in the perfused rat lung: an application of the multiple-indicator dilution method.
    Sato H; Terasaki T; Tsuji A
    J Pharm Pharmacol; 1990 Dec; 42(12):879-82. PubMed ID: 1983155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
    Itoh J; Ukai M; Kameyama T
    J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different modulation of cholinergic neuronal systems by dynorphin A (1-13) in carbon monoxide-exposed mice.
    Hiramatsu M; Murai M; Kameyama T
    Biochem Pharmacol; 1999 Jun; 57(11):1321-9. PubMed ID: 10230776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic administration of dynorphin A(1-13) markedly inhibits different behavioural responses induced by cocaine in the mouse.
    Ukai M; Kamiya T; Toyoshi T; Kameyama T
    Neuropharmacology; 1992 Sep; 31(9):843-9. PubMed ID: 1359442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers.
    Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Wilson D; Yu J; Vetticaden S
    Curr Med Res Opin; 2017 Nov; 33(11):1921-1933. PubMed ID: 28942715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats.
    Zhou Q; Carlsson A; Hallberg M; Nyberg F
    Peptides; 2011 Aug; 32(8):1661-5. PubMed ID: 21763376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to stress alters the effects of dynorphins in the hot plate test.
    Starec M; Nejedlý A; Málek J; Rosina J; Gojisová E; Krsiak M
    Physiol Res; 1997; 46(6):451-7. PubMed ID: 9730052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: the metabolism of dynorphin A1-13 and related fragments in human plasma.
    Müller S; Hutson A; Arya V; Hochhaus G
    J Pharm Sci; 1999 Sep; 88(9):938-44. PubMed ID: 10479358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.
    Qu ZX; Isaac L
    Brain Res; 1993 May; 610(2):340-3. PubMed ID: 8100473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.
    Morgan M; Heffernan A; Benhabib F; Wagner S; Hewavitharana AK; Shaw PN; Cabot PJ
    Peptides; 2017 Mar; 89():9-16. PubMed ID: 28049031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.